CATEQUENTINIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 41 adverse event reports in the FDA FAERS database where CATEQUENTINIB was used for Lung neoplasm malignant.
Most Reported Side Effects for CATEQUENTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 84 | 25.9% | 5 | 35 |
| Off label use | 37 | 11.4% | 14 | 6 |
| Diarrhoea | 33 | 10.2% | 4 | 4 |
| Hypertension | 26 | 8.0% | 1 | 2 |
| Nausea | 26 | 8.0% | 3 | 1 |
| Vomiting | 26 | 8.0% | 2 | 1 |
| Rash | 25 | 7.7% | 3 | 3 |
| Thrombocytopenia | 24 | 7.4% | 2 | 0 |
| Fatigue | 23 | 7.1% | 2 | 0 |
| Anaemia | 22 | 6.8% | 3 | 0 |
| Decreased appetite | 22 | 6.8% | 2 | 3 |
| Leukopenia | 21 | 6.5% | 1 | 0 |
| Disease progression | 20 | 6.2% | 3 | 3 |
| Hypothyroidism | 20 | 6.2% | 2 | 3 |
| Neutropenia | 19 | 5.9% | 2 | 1 |
Other Indications for CATEQUENTINIB
Non-small cell lung cancer (24)
Lung adenocarcinoma (20)
Small cell lung cancer extensive stage (19)
Small cell lung cancer (12)
Oesophageal carcinoma (10)
Breast cancer (8)
Breast cancer metastatic (7)
Colorectal cancer metastatic (7)
Lung adenocarcinoma stage iv (7)
Ovarian cancer (7)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)